Morphic to present at 2023 rbc capital markets global healthcare conference

Waltham, mass., may 12, 2023 (globe newswire) -- morphic therapeutic (nasdaq: morf), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that its management team will participate in a fireside chat at the 2023 rbc capital markets global healthcare conference on wednesday, may 17, 2023.
MORF Ratings Summary
MORF Quant Ranking